Testosterone replacement therapy and cardiovascular risk factors modification

Author： Chahla Elie J.   Hayek Mireille El   Morley John E.  

Publisher： Informa Healthcare

ISSN： 1473-0790

Source： The Aging Male, Vol.14, Iss.2, 2011-06, pp. : 83-90

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Testosterone replacement therapy improves erythrocyte membrane lipid composition in hypogonadal men

By Angelova Petya  

The Aging Male, Vol. 15, Iss. 3, 2012-09 ,pp. : 173-179

Informa Healthcare

Access to resources Recommend Favorite

Testosterone replacement therapy by testosterone ointment relieves lower urinary tract symptoms in late onset hypogonadism patients

By Amano Toshiyasu   Imao Tetsuya   Takemae Katsurou   Iwamoto Teruaki   Nakanome Mariko  

The Aging Male, Vol. 13, Iss. 4, 2010-12 ,pp. : 242-246

Informa Healthcare

Access to resources Recommend Favorite

Testosterone and cardiovascular disease in men

By Rothman Micol S   Wierman Margaret E  

Aging Health, Vol. 3, Iss. 3, 2007-06 ,pp. : 375-381

Future Medicine

Access to resources Recommend Favorite

Low-intermediate dose testosterone replacement therapy by different pharmaceutical preparations improves frailty score in elderly hypogonadal hyperglycaemic patients

By Strollo Felice  

The Aging Male, Vol. 16, Iss. 2, 2013-06 ,pp. : 33-37

Informa Healthcare

Access to resources Recommend Favorite

Testosterone and cardiovascular risk: world’s experts take unprecedented action to correct misinformation

By Morgentaler Abraham   Lunenfeld Bruno  

The Aging Male, Vol. 17, Iss. 2, 2014-06 ,pp. : 63-65

Informa Healthcare

Access to resources Recommend Favorite